On August 29, 2024 Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, reported that it will webcast its presentations at three investor conferences in September. The presentations will feature a business overview and update (Press release, Sana Biotechnology, AUG 29, 2024, View Source [SID1234646209]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Sana will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 11:30 a.m. ET on Wednesday, September 4, 2024.
Sana will present at the 2024 Wells Fargo Healthcare Conference at 3:00 p.m. ET on Thursday, September 5, 2024.
Sana will present at the HC Wainwright 26th Annual Global Investment Conference at 12:30 p.m. ET on Monday, September 9, 2024.

The webcasts will be accessible on the Investor Relations page of Sana’s website at View Source A replay of each presentation will be available at the same location for 30 days following the conference.